Terms: = Sarcomas AND AXIN1, LA16c-314G4_3, 8312, ENSG00000103126, O15169, AXIN, MGC52315 AND Treatment
11683 results:
1. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on sarcomas (GEIS) study.
Moura DS; Mondaza-Hernandez JL; Sanchez-Bustos P; Peña-Chilet M; Cordero-Varela JA; Lopez-Alvarez M; Carrillo-Garcia J; Martin-Ruiz M; Romero-Gonzalez P; Renshaw-Calderon M; Ramos R; Marcilla D; Alvarez-Alegret R; Agra-Pujol C; Izquierdo F; Ortega-Medina L; Martin-Davila F; Hernandez-Leon CN; Romagosa C; Salgado MAV; Lavernia J; Bagué S; Mayodormo-Aranda E; Alvarez R; Valverde C; Martinez-Trufero J; Castilla-Ramirez C; Gutierrez A; Dopazo J; Hindi N; Garcia-Foncillas J; Martin-Broto J
Cell Mol Life Sci; 2024 May; 81(1):219. PubMed ID: 38758230
[TBL] [Abstract] [Full Text] [Related]
2. Cell Cycle Checkpoints p16 and p21-Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma.
Nasri E; Torrence DE; Vasilopoulos T; Knapik JA; Lagmay JP; Reith JD; Gibbs CP
Cancer J; 2024 May-Jun 01; 30(3):133-139. PubMed ID: 38753746
[TBL] [Abstract] [Full Text] [Related]
3. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
[TBL] [Abstract] [Full Text] [Related]
5. Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study.
Hompland I; Boye K; Wiedswang AM; Papakonstantinou A; Røsok B; Joensuu H; Bruland Ø
Acta Oncol; 2024 May; 63():288-293. PubMed ID: 38712513
[TBL] [Abstract] [Full Text] [Related]
6. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
[TBL] [Abstract] [Full Text] [Related]
7. [Analysis of the effect of different facial nerve managements applied to tumor resection in the jugular foramen region].
Yin Y; Zhao Y; Tian X; Zhao Y; Chen H; Zhang L; Gao Z; Feng G
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):368-371;375. PubMed ID: 38686470
[No Abstract] [Full Text] [Related]
8. Targeting KRAS in pancreatic cancer.
Stickler S; Rath B; Hamilton G
Oncol Res; 2024; 32(5):799-805. PubMed ID: 38686056
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy and Toxicity of Vincristine and CYP3A5 Genetic Polymorphism in Rhabdomyosarcoma Pediatric Egyptian Patients.
Shalaby N; Zaki HF; Badary OA; Kamal S; Nagy M; Makhlouf D; Elnashar A; Elnadi E; Abdelshafi SA; Abouelnaga S; Saber MM
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1391-1409. PubMed ID: 38680001
[TBL] [Abstract] [Full Text] [Related]
10. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
11. Advancements in Photothermal Therapy Using Near-Infrared Light for Bone Tumors.
Xie M; Gong T; Wang Y; Li Z; Lu M; Luo Y; Min L; Tu C; Zhang X; Zeng Q; Zhou Y
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673726
[TBL] [Abstract] [Full Text] [Related]
12. Tumours of the foot: A 10 years retrospective analysis.
Ajit Singh V; Sandhu V; Tze Yong C; Yasin NF
J Orthop Surg (Hong Kong); 2024; 32(1):10225536241248706. PubMed ID: 38662594
[TBL] [Abstract] [Full Text] [Related]
13. Biomechanical and clinical outcomes of 3D-printed versus modular hemipelvic prostheses for limb-salvage reconstruction following periacetabular tumor resection: a mid-term retrospective cohort study.
Hu X; Wen Y; Lu M; Luo Y; Zhou Y; Yang X; Tu C; Min L
J Orthop Surg Res; 2024 Apr; 19(1):258. PubMed ID: 38654343
[TBL] [Abstract] [Full Text] [Related]
14. Associations Between Stress, Health Behaviors, and Quality of Life in Young Couples During the Transition to Survivorship: Protocol for a Measurement Burst Study.
Cho D; Roth M; Peterson SK; Jennings K; Kim S; Weathers SP; Ahmed S; Livingston JA; Barcenas C; You YN; Milbury K
JMIR Res Protoc; 2024 Apr; 13():e53307. PubMed ID: 38652520
[TBL] [Abstract] [Full Text] [Related]
15. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
16. Preclinical evaluation and first-in-dog clinical trials of PBMC-expanded natural killer cells for adoptive immunotherapy in dogs with cancer.
Razmara AM; Farley LE; Harris RM; Judge SJ; Lammers M; Iranpur KR; Johnson EG; Dunai C; Murphy WJ; Brown CT; Rebhun RB; Kent MS; Canter RJ
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38631708
[TBL] [Abstract] [Full Text] [Related]
17. Local recurrence in malignant peripheral nerve sheath tumours: multicentre cohort study.
Jansma CYMN; Acem I; Grünhagen DJ; Verhoef C; Martin E;
BJS Open; 2024 Mar; 8(2):. PubMed ID: 38620136
[TBL] [Abstract] [Full Text] [Related]
18. Design, Synthesis, and Anti-Leukemic Evaluation of a Series of Dianilinopyrimidines by Regulating the Ras/Raf/MEK/ERK and STAT3/c-Myc Pathways.
Wang C; Wang B; Mou Y; Liu X; Chen Q; Pu W; Rao Q; Wang C; Song J; Huang Y; Yan L; Huang L; Li Y
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611876
[TBL] [Abstract] [Full Text] [Related]
19. Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma.
Naghavi AO; Bryant JM; Kim Y; Weygand J; Redler G; Sim AJ; Miller J; Coucoules K; Michael LT; Gloria WE; Yang G; Rosenberg SA; Ahmed K; Bui MM; Henderson-Jackson EB; Lee A; Lee CD; Gonzalez RJ; Feygelman V; Eschrich SA; Scott JG; Torres-Roca J; Latifi K; Parikh N; Costello J
BMC Cancer; 2024 Apr; 24(1):437. PubMed ID: 38594603
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of NEK2 Promotes Chemosensitivity and Reduces KSHV-positive Primary Effusion Lymphoma Burden.
White MC; Wong JP; Damania B
Cancer Res Commun; 2024 Apr; 4(4):1024-1040. PubMed ID: 38592451
[TBL] [Abstract] [Full Text] [Related]
[Next]
